Clinical Trial Update: An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates [Phase 1]

View source ↗

Summary

An open-label Phase 1 study evaluating whether BCX7353 affects cytochrome P450 enzyme activity using probe substrates to assess potential drug-drug interactions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• BCX7353

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema | Phase 1 | Status: COMPLETED